OSG

Business Context and Reporting Period

Company: Octave Specialty Group, Inc. (OSG)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Three months ended March 31, 2026
Business Overview: OSG operates two primary segments: Insurance Distribution (ID) and Specialty Property & Casualty (P&C) Insurance. The ID segment includes Managing General Agents (MGAs) and brokers, while the P&C segment operates through the Everspan group of carriers. The company completed the sale of its Legacy Financial Guarantee business (Ambac Assurance Corporation) in September 2025, reporting those results as discontinued operations.

Key Financial Metrics

Note: Q1 2025 results include a significant loss from discontinued operations ($30,247) related to the sale of Ambac Assurance Corporation, which is excluded from continuing operations in Q1 2026.

Material Changes vs. Prior Period

• Revenue Growth: Total revenues increased 66% to $104.2 million, driven primarily by the Insurance Distribution segment. Commission income rose 85% to $68.2 million due to the acquisition of ArmadaCorp (closed Oct 2025) and organic growth.
• Profitability Improvement: Net loss attributable to shareholders narrowed significantly to $(6.9) million from $(46.4) million. This improvement is largely due to the absence of the discontinued operations loss in the current period and strong performance in the ID segment.
• Segment Performance:
  • Insurance Distribution: Reported pretax income of $16.8 million (vs. loss of $2.2 million in Q1 2025). EBITDA increased to $30.8 million.
  • Specialty P&C: Reported a pretax loss of $(8.3) million (vs. income of $1.5 million in Q1 2025). The loss was driven by a combined ratio of 149.7%, impacted by a litigation settlement ($2.1M net losses + $5.8M legal expenses) and reserve strengthening.
• Balance Sheet: Total assets increased by $43.7 million, primarily due to growth in reinsurance recoverables and commission receivables. Liabilities increased by $100.3 million, largely due to payables for the acquisition of noncontrolling interests (NCI) via put option exercises.

Guidance, Outlook, and Risks

• Capital Management: Between March 31 and April 9, 2026, OSG paid approximately $43.9 million to acquire redeemable NCI shares following put option exercises. The company funded this via cash and an amendment to its credit facility (adding $40 million to the term loan).
• Outlook: Management expects the Insurance Distribution segment to continue growing through organic expansion and acquisitions. The Specialty P&C segment is building production levels, though results may be volatile due to the nature of underwriting and potential inflation impacts on loss costs.
• Risks and Contingencies:
  • Legal Proceedings: OSG is involved in the "COFINA Case" (Dwight Jereczek v. MBIA Inc., etc.). While claims against OSG and Ambac Assurance were dismissed for lack of personal jurisdiction in February 2026, plaintiffs may refile claims.
  • Underwriting Volatility: The Specialty P&C segment faces risks from economic/social inflation, judicial system disruptions, and the inherent uncertainty of loss reserve estimates.
  • Liquidity: OSG's liquidity depends on distributions from subsidiaries and access to credit facilities. Future put/call exercises may require additional capital.

Investor Verification Checklist

• NCI Put Option Exercises: Verify the impact of the $43.9 million cash outflow for NCI acquisitions on future liquidity and debt covenants.
• Specialty P&C Loss Development: Review the details of the litigation settlement ($7.9M total impact) and assess the sustainability of the 149.7% combined ratio.
• Discontinued Operations: Confirm that the Q1 2025 comparison is adjusted for the one-time loss on the sale of Ambac Assurance Corporation to accurately assess organic growth.
• Debt Covenants: Monitor compliance with the amended 2025 Credit Facility, particularly regarding financial ratios and restricted payments.
• Legal Status: Track the status of the COFINA litigation to ensure no re-filing of claims against OSG entities.